TABLE 2.
AEPTa | Km of AEP (mM) | Km of pyruvate (mM) | Km of P-Ald (mM) | Km of l-Ala (mM) | kcat (s−1)→P-Aldb | kcat (s−1)→AEPc |
---|---|---|---|---|---|---|
Wild type | 1.11 ± 0.03 | 0.150 ± 0.02 | 0.09 ± 0.01 | 1.4 ± 0.3 | 7.4 | 9.3 |
D168A | NAd | NA | NA | NA | NA | ≤1 × 10−4 |
K194R | NA | NA | NA | NA | NA | ≤1 × 10−4 |
K194L | NA | NA | NA | NA | NA | ≤1 × 10−4 |
R340K | −e | 0.50 ± 0.05 | 2.9 ± 0.4 | 20 ± 1 | 0.2 | 0.6 |
R340A | 26 ± 1 | 6.1 ± 0.3 | 0.19 ± 0.01 | 140 ± 70 | 0.2 | 0.2 |
The 1-ml assay solution for the direction of P-Ald formation contains 0.5 mM β-NADH, 100 μM PLP, 10 U of ADH, 2 U of phosphonatase, and 5 mM MgCl2 in 50 mM K+TRICINE (pH 8.5) at various concentrations of AEP (5 to 40 mM) with 5 mM pyruvate or various concentrations of pyruvate (0.4 to 7 mM) with 20 mM AEP. The 1-ml assay solution for the direction of AEP formation contains 0.5 mM β-NADH, 100 μM PLP, 10 U of LDH, and 5 mM MgCl2 in 50 mM K+TRICINE (pH 8.5) at various concentrations of P-Ald (0.25 to 10 mM) with 20 mM l-Ala or various concentrations of l-Ala (3 to 20 mM) with 5 mM P-Ald.
→P-Ald, in the direction of P-Ald formation.
→AEP, in the direction of AEP formation.
NA, no activity.
The Km was too large to measure.